Heart & Hypertension Test / Packages

Lipoprotein(a) [Lp(a)] is a type of lipoprotein particle composed of a cholesterol-rich LDL-like core and an additional protein called apolipoprotein(a). Lp(a) is synthesized in the liver and circulates in the bloodstream, where it plays a role in lipid transport and metabolism. Elevated levels of Lp(a) are genetically determined and can contribute to an increased risk of cardiovascular diseases, including coronary artery disease, stroke, and peripheral artery disease. Lp(a) levels are measured through blood tests and are influenced by genetic factors inherited from parents. It is considered a unique risk factor independent of traditional lipid markers such as LDL cholesterol. Research indicates that high Lp(a) levels may promote atherosclerosis by facilitating the deposition of cholesterol in arterial walls. Management of elevated Lp(a) levels typically involves lifestyle modifications (e.g., diet, exercise) and, in some cases, medication to reduce cardiovascular risk. Regular monitoring of Lp(a) levels is recommended for individuals with a family history of premature cardiovascular disease or those at higher risk.

Aldolase is an enzyme crucial for carbohydrate metabolism, specifically involved in the breakdown of glucose for energy production. It catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate during glycolysis, a fundamental process in cellular energy generation. Aldolase exists in three isoforms: aldolase A in muscle tissue, aldolase B in liver and kidney tissue, and aldolase C in brain and nervous tissue. Elevated levels of aldolase in the blood can indicate tissue damage or disease, particularly in conditions affecting muscle or liver function. Aldolase testing is used in clinical settings to diagnose and monitor various metabolic disorders and muscle diseases.

Homocysteine is an amino acid produced during the metabolism of methionine, an essential amino acid obtained from dietary proteins. Elevated levels of homocysteine in the blood are associated with increased risk of cardiovascular disease, stroke, and other vascular conditions. Homocysteine levels are influenced by genetic factors and dietary intake of vitamins such as folate, vitamin B6, and vitamin B12, which are essential for its metabolism. Elevated homocysteine levels may indicate deficiencies in these vitamins or impaired enzymatic processes responsible for homocysteine conversion. Testing homocysteine levels helps assess cardiovascular risk and guide interventions, including dietary changes and supplementation with B vitamins to lower homocysteine levels and reduce associated health risks.

Lactate dehydrogenase (LDH) is an enzyme found in many tissues of the body, including the heart, liver, kidneys, muscles, and red blood cells. It plays a crucial role in cellular metabolism by catalyzing the conversion of lactate to pyruvate and vice versa, depending on the metabolic needs of the cell. LDH levels in the blood are measured to assess tissue damage or disease. Elevated LDH levels may indicate tissue injury, such as from heart attacks, liver disease, muscle damage, or certain cancers. LDH testing is often included in diagnostic panels to help identify and monitor various medical conditions affecting multiple organ systems.

A lipoprotein test measures the levels of lipoproteins in the blood. Lipoproteins are molecules that transport cholesterol and triglycerides through the bloodstream. This test typically includes measurements of low-density lipoprotein (LDL), high-density lipoprotein (HDL), and sometimes very low-density lipoprotein (VLDL). It helps assess the risk of cardiovascular diseases, such as heart disease and stroke, by evaluating cholesterol levels and their distribution within different types of lipoproteins.

An Apolipoprotein A1 (Apo A1) test measures the level of Apo A1 protein in the blood. Apo A1 is the main protein component of high-density lipoprotein (HDL), known as "good cholesterol." It helps transport cholesterol from the arteries to the liver for removal. This test assesses cardiovascular disease risk, with low Apo A1 levels indicating a higher risk and higher levels being protective. It's used alongside other lipid tests to evaluate heart health.

Apo B (Apolipoprotein B) measures the level of this protein in the blood, which is a key component of low-density lipoprotein (LDL) and other atherogenic lipoproteins. Apo B is crucial for assessing cardiovascular risk, as it reflects the number of potentially harmful lipoprotein particles that can contribute to plaque buildup in the arteries. High levels of Apo B are associated with an increased risk of heart disease. This test helps evaluate overall heart health and guide treatment strategies.

The Apolipoprotein B/A1 ratio measures the balance between two key proteins in lipid metabolism: Apolipoprotein B (Apo B) and Apolipoprotein A1 (Apo A1). Apo B is the primary protein component of low-density lipoprotein (LDL) and other atherogenic particles, while Apo A1 is the main protein component of high-density lipoprotein (HDL), which helps remove cholesterol from the bloodstream. This ratio provides insight into cardiovascular risk by comparing the levels of these two proteins. A high Apo B/A1 ratio indicates a higher number of potentially harmful lipoprotein particles (associated with LDL) relative to the protective HDL particles (associated with Apo A1). A higher ratio is linked to an increased risk of developing cardiovascular diseases, as it reflects an imbalance between pro-atherogenic and anti-atherogenic lipoproteins. This ratio is used alongside other lipid profile measurements to evaluate overall heart health and guide treatment decisions.

The homocysteine test measures the level of homocysteine, an amino acid, in the blood. Elevated levels of homocysteine can be an indicator of various health issues, including a higher risk of cardiovascular diseases such as heart attack and stroke, as well as other conditions like blood clots and cognitive decline. Homocysteine is produced during the metabolism of methionine, another amino acid. Typically, the body breaks down homocysteine with the help of vitamins B6, B12, and folate. Low levels of these vitamins can lead to increased homocysteine levels. The test is often used to assess cardiovascular risk, particularly in individuals with a family history of heart disease or those with other risk factors. It can also help diagnose vitamin deficiencies and monitor conditions that affect homocysteine metabolism.

High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation in the body, specifically used to assess low-grade inflammation associated with cardiovascular disease and other chronic conditions. It is a sensitive biomarker that can detect subtle changes in inflammation levels, helping to predict cardiovascular risk beyond traditional risk factors like cholesterol levels. hsCRP testing is performed using a blood sample and is particularly useful in stratifying cardiovascular risk in individuals with intermediate risk profiles. Elevated hsCRP levels may indicate increased risk for heart attacks, strokes, and other cardiovascular events, prompting interventions such as lifestyle changes and medications to mitigate risk.

A troponin T qualitative test measures the presence of troponin T proteins in the blood, indicating heart muscle damage. Troponin T is released into the bloodstream when the heart muscle is injured, such as during a heart attack. The qualitative test doesn't quantify the amount but confirms if troponin T is detectable, helping diagnose acute coronary syndromes and other heart conditions. It's a crucial early indicator in emergency settings for evaluating patients with chest pain.

B-type natriuretic peptide (BNP) measures the level of BNP in the blood, a hormone produced by the heart's ventricles. BNP levels increase when the heart is under stress and struggling to pump blood effectively, such as in heart failure. Measuring BNP helps diagnose and assess the severity of heart failure, differentiate cardiac from non-cardiac causes of symptoms like shortness of breath, and guide treatment decisions. Elevated BNP levels indicate worsening heart function and fluid overload.

A triglycerides test measures the level of triglycerides in the blood, which are a type of fat (lipid). Elevated triglyceride levels can indicate an increased risk of cardiovascular disease, pancreatitis, and metabolic disorders. High levels often result from excess calorie consumption, obesity, uncontrolled diabetes, excessive alcohol intake, or genetic conditions. Monitoring triglycerides helps assess heart health and guide lifestyle or medical interventions to reduce the risk of heart disease and other related conditions.

A cardiolipin antibody IgA test measures the level of IgA antibodies against cardiolipin, a type of lipid found in cell membranes. Elevated levels of these antibodies can indicate an increased risk of autoimmune conditions, particularly antiphospholipid syndrome (APS), which can lead to blood clotting disorders and complications during pregnancy. The test is often used to assess the presence of APS, especially when combined with other antiphospholipid antibodies tests, to evaluate thrombotic risk and guide treatment.

A cardiolipin antibodies IgM test measures the level of immunoglobulin M (IgM) antibodies against cardiolipin, a lipid found in cell membranes. Elevated IgM levels can indicate antiphospholipid syndrome (APS), an autoimmune condition that increases the risk of abnormal blood clotting, leading to issues like deep vein thrombosis, stroke, or recurrent miscarriages. The test is used to assess the likelihood of APS and guide further diagnostic and treatment decisions, often alongside other antiphospholipid antibody tests.

High-Density Lipoprotein (HDL) cholesterol measures the level of HDL in the blood. HDL is often referred to as "good" cholesterol because it helps remove excess cholesterol from the bloodstream and transports it to the liver for excretion. Higher HDL levels are associated with a lower risk of cardiovascular disease, as it aids in preventing the buildup of plaque in the arteries. Monitoring HDL cholesterol levels helps assess cardiovascular health and guide prevention strategies.

NT-proBNP (N-terminal pro b-type natriuretic peptide) is a blood test that measures the levels of NT-proBNP, a substance produced in the heart and released into the blood when the heart is under stress or working hard to pump blood. Elevated levels of NT-proBNP indicate heart failure or other cardiac conditions, such as left ventricular dysfunction. This test is used to help diagnose heart failure, assess its severity, and monitor the effectiveness of treatment. It is also useful in distinguishing between cardiac and non-cardiac causes of symptoms like shortness of breath.

Total cholesterol measures the overall amount of cholesterol in the blood, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and very low-density lipoprotein (VLDL). LDL is often termed "bad" cholesterol as it can lead to plaque buildup in arteries, while HDL is considered "good" cholesterol because it helps remove LDL from the bloodstream. VLDL is another type of cholesterol linked to triglycerides. Monitoring total cholesterol helps assess cardiovascular health and the risk of heart disease.

A comprehensive cardiac profile is a detailed assessment used to evaluate an individual’s cardiovascular health and risk factors for heart disease. This profile typically includes a variety of tests and measurements. Key components often include lipid panels, which measure total cholesterol, LDL (bad cholesterol), HDL (good cholesterol), and triglycerides. Other important markers are blood pressure readings and blood glucose levels, which help assess metabolic health. Additionally, apolipoprotein levels (Apo A1 and Apo B) provide insights into cardiovascular risk. Advanced imaging tests like echocardiograms or stress tests may also be included to assess heart function and detect abnormalities. Family history, lifestyle factors (such as diet, physical activity, and smoking), and body mass index (BMI) are also considered. By analyzing this comprehensive data, healthcare providers can develop targeted prevention and treatment strategies, ultimately aiming to reduce the risk of cardiovascular events and promote heart health.

The Standard Healthy Heart Package is a comprehensive health checkup designed to assess heart health and detect potential cardiovascular issues early. This package typically includes a series of tests that evaluate the overall condition of your heart and related systems, ensuring timely intervention and prevention of complications. This package is ideal for individuals over 30, those with a family history of heart disease, or anyone experiencing symptoms like chest pain or breathlessness. It promotes early detection, empowering individuals to make informed decisions about their heart health. Regular monitoring ensures longevity and improved quality of life.

Here's a summary of what each component measures in the context of cardiovascular health: 1. **Apolipoprotein A (Apo A)**: Measures levels of HDL cholesterol, indicating protective effects against heart disease. 2. **Apolipoprotein B (Apo B)**: Measures levels of LDL cholesterol and other atherogenic particles, reflecting cardiovascular disease risk. 3. **Apolipoprotein A1/B Ratio**: Assesses the balance between protective (Apo A1) and harmful (Apo B) lipoproteins, providing insights into cardiovascular risk. 4. **Lipid Profile**: Includes total cholesterol, LDL, HDL, and triglycerides, offering a comprehensive overview of lipid levels and cardiovascular health risk. Together, these measurements help evaluate lipid metabolism and cardiovascular disease risk.

An electrolyte panel measures the levels of key electrolytes in the blood, including sodium, potassium, chloride, and bicarbonate. These electrolytes are crucial for maintaining fluid balance, nerve function, and muscle contractions. The panel helps assess overall health, diagnose conditions related to imbalances, such as dehydration, kidney disease, or acid-base disorders, and monitor the effects of treatments. Abnormal results can indicate issues with fluid and electrolyte balance, requiring further evaluation and management.

TheXpertLab @ 96 Tests ADVANCE HEART CARE PACKAGE

TheXpertLab @ 89 Test BASIC HEART CARE PACKAGE

A cardiac risk marker is a biological indicator that helps assess an individual's likelihood of developing cardiovascular diseases. These markers can include lipid profiles, such as total cholesterol, LDL, HDL, and triglycerides, as well as specific proteins like C-reactive protein (CRP) and lipoprotein(a). Advanced cardiac risk markers may also encompass genetic factors, inflammatory markers, and imaging techniques that evaluate arterial health. By analyzing these indicators, healthcare professionals can identify patients at higher risk for heart attacks, strokes, or other cardiovascular events. This information aids in creating personalized prevention strategies, monitoring treatments, and improving overall heart health management.

Troponin I measures the level of troponin I protein in the blood, which is released when heart muscle cells are damaged. It is a key biomarker for myocardial injury, commonly used to diagnose heart attacks and other acute coronary conditions. Elevated troponin I levels indicate damage to the heart muscle, helping clinicians assess the severity of the injury, monitor the progression of cardiac conditions, and guide treatment strategies. This test is specific to cardiac muscle damage.

A Troponin T quantitative test measures the level of troponin T protein in the blood, which is released when heart muscle cells are damaged. Elevated troponin T levels indicate myocardial injury, such as a heart attack or other conditions affecting the heart muscle. This test is crucial for diagnosing acute coronary syndromes, assessing the extent of heart damage, and guiding treatment decisions. It provides valuable information about the heart's condition and helps in managing cardiovascular health.

A lipid profile is a blood test measuring cholesterol and triglycerides, including total cholesterol, LDL (bad) cholesterol, HDL (good) cholesterol, and triglycerides, to assess cardiovascular health.

A cortisol morning test measures the level of cortisol, a hormone produced by the adrenal glands, in the blood. Cortisol levels naturally peak in the early morning and decrease throughout the day. This test is typically performed in the morning to evaluate adrenal gland function and diagnose conditions such as Cushing's syndrome (high cortisol) or Addison's disease (low cortisol). By assessing morning cortisol levels, healthcare providers can better understand the body's stress response and hormonal balance.

An evening cortisol test measures the level of cortisol, a hormone produced by the adrenal glands, in the blood or saliva during the evening. Cortisol follows a natural diurnal rhythm, typically peaking in the morning and declining throughout the day. Measuring evening cortisol levels is crucial for diagnosing disorders related to cortisol production, such as Cushing's syndrome, where cortisol levels remain abnormally high throughout the day, or Addison's disease, where cortisol levels may be inappropriately low. Abnormal evening cortisol levels can also indicate issues with the hypothalamic-pituitary-adrenal (HPA) axis. This test helps assess adrenal function and diagnose conditions related to cortisol dysregulation.

The Anti-Streptolysin O (ASO) test measures the level of antibodies against streptolysin O, a toxin produced by group A Streptococcus bacteria. Here's what it indicates: - **Streptolysin O:** A toxin produced by Streptococcus pyogenes (group A strep) that can cause cell damage. - **ASO Antibodies:** The immune system produces antibodies against streptolysin O when infected by group A strep. **Test Purpose:** - **Diagnosis of Recent Strep Infection:** Elevated ASO levels suggest a recent or past infection with group A strep. - **Rheumatic Fever and Glomerulonephritis:** Helps diagnose complications like rheumatic fever or post-streptococcal glomerulonephritis, which can develop after a strep infection. **Interpretation:** - **High ASO Levels:** Indicate a recent streptococcal infection. - **Normal ASO Levels:** Do not rule out strep infection, especially if the test is performed too early or if the individual has a different immune response. The ASO test aids in diagnosing and managing complications arising from streptococcal infections.

Creatine kinase-MB (CK-MB) mass is an enzyme primarily found in the heart muscle (myocardium). It is a specific form of creatine kinase that plays a crucial role in diagnosing acute myocardial infarction (heart attack). CK-MB levels rise significantly within 4-6 hours after the onset of myocardial injury and peak around 12-24 hours, making it a valuable marker for early detection of cardiac damage. CK-MB mass is measured through a blood test and is used alongside other cardiac biomarkers, such as troponin, to confirm or rule out a heart attack. Elevated levels of CK-MB mass indicate myocardial damage, guiding timely interventions and treatment decisions to minimize cardiac tissue injury and improve patient outcomes.

A CPK-NAC (Creatine Phosphokinase-N-acetylcysteine) test measures the level of creatine phosphokinase (CPK) in the blood after the addition of N-acetylcysteine (NAC), which helps stabilize and preserve the enzyme. CPK is an enzyme found in the heart, brain, and muscles, and its levels can indicate muscle damage or stress. This test is used to assess and monitor conditions like myocardial infarction, muscular dystrophy, and other muscle-related disorders by evaluating changes in CPK levels.

Cardiac risk measures the likelihood of developing cardiovascular diseases, including heart attacks and strokes. It typically includes a combination of factors such as cholesterol levels (total cholesterol, LDL, HDL), triglycerides, blood pressure, blood sugar levels, body mass index (BMI), and lifestyle factors (smoking, physical activity, diet). Biomarkers like C-reactive protein (CRP) and lipoprotein(a) may also be assessed. Family history and age are important risk factors as well. Healthcare providers use these measurements to evaluate overall heart health, identify individuals at higher risk, and develop targeted prevention strategies or treatment plans to reduce the risk of cardiovascular events.

The Common Cardiac Package is a tailored health checkup aimed at detecting and preventing heart-related conditions. This package includes essential tests to evaluate cardiac health, identify risk factors, and guide proactive care to maintain heart function and prevent serious complications. This package is suitable for individuals with a family history of heart conditions, those leading sedentary lifestyles, or anyone experiencing symptoms like chest discomfort, palpitations, or fatigue. By offering a comprehensive assessment, the Common Cardiac Package helps in early diagnosis and management of heart health, encouraging a proactive approach to long-term well-being.